The cobas® c 703 and cobas® ISE neo analytical units, deliver higher testing capacity and increased automation helping to improve laboratory workflows and advance patient care. The new cobas c 703 ...
With eight new configurations, cobas pro® integrated solutions offers labs greater flexibility to ramp up their testing capacity to adapt to evolving testing needs This will allow a greater number of ...
INDIANAPOLIS, Sept. 19, 2022 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the cobas ® pure integrated solutions, ...
Roche announced the launch of its new analytical units, cobas c 703 and cobas ISE neo, for the cobas pro integrated solutions, in countries accepting the CE mark. The cobas pro integrated solutions is ...
About cobas pro integrated solutions Launched in 2018, cobas pro integrated solutions is a scalable and modular solution designed to meet mid-to-very-high volume clinical chemistry and immunochemistry ...